ArticleAdvances in therapy2019

The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia.

Samuel J P Malkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.